Classes
- Internal Medicine - Hematology +1B00307 | First Faculty of Medicine
- Internal Medicine - SE +1B00073 | First Faculty of Medicine
- Review of Internal Diseases 1B00341 | First Faculty of Medicine
- Review of Internal Diseases 2B00355 | First Faculty of Medicine
- Ultrasonographic and Endoscopic TechnologyB00816 | First Faculty of Medicine
- Internal Medicine Practice before State Examination +1B01056 | First Faculty of Medicine
- Review of Internal Medicine - Rehabilitation 1B01536 | First Faculty of Medicine
- Diagnosis and therapy in haematology - ethical issuesB02094 | First Faculty of Medicine
- Laboratory Methods in Hematology - Diagnostic Tool and Translation´s Research +1B02551 | First Faculty of Medicine
- News in hematology and blood transfusionB02697 | First Faculty of Medicine
Publications
- The effect of allogeneic stem cell transplantation on high risk chronic lymphocytic leukaemia: a single centre retrospective analysis2011 | First Faculty of Medicine
- MYB transcriptionally regulates the miR-155 host gene in chronic lymphocytic leukemia2011 | First Faculty of Medicine
- The evaluation of survival and proliferation of lymphocytes in autologous mixed leukocyte reaction with dendritic cells. The comparison of incorporation of (3)H-thymidine and differential gating method2011 | First Faculty of Medicine
- Analysis of absolute lymphocyte count and other factors predicting survival in patients with Hodgkin's lymphoma following autologous stem cell transplantation2010 | First Faculty of Medicine, Faculty of Physical Education and Sport
- New prognostic markers of chronic lymphocytic leukemia (CLL) in the everyday hematological practice : an analysis of data from four hematology departments2010 | First Faculty of Medicine
- Telomere length, molecular cytogenetic findings, and immunophenotypic features in previously untreated patients with B-chronic lymphocytic leukemia2010 | First Faculty of Medicine
- Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial.2010 | First Faculty of Medicine
- Molecular remission is an independent predictor of clinical outcome in patients with mantle cell lymphoma after combined immunochemotherapy: a European MCL intergroup study.2010 | First Faculty of Medicine
- Non-Hodgkin's lymphomas2010 | First Faculty of Medicine
- Clonal evolution in chronic lymphocytic leukemia studied by interphase fluorescence in-situ hybridization2009 | First Faculty of Medicine
Loading network view...